Sodium-glucose link transporter-2 inhibitors in reduced renal function: Cross-class comparison from the Association of British Clinical Diabetologists (ABCD) audits.
Authors:
TSJ Crabtree, A Bickerton, K Dhatariya, A Gallagher, J Elliott, R Raghavan, IW Gallen, REJ Ryder on behalf of all ABCD SGLT2 audit contributors.
Which DIYAPS systems and are people using in the United Kingdom? Insights from the Association of British Clinical Diabetologist’s (ABCD) DIYAPS audit programme.
Authors:
TSJ Crabtree, S Hussain, B Mendis, T Gazis, R Herring, I Idris REJ Ryder, EG Wilmot
Glycaemic and safety outcomes associated with do-it-yourself artificial pancreas systems (DIYAPS): Initial insights from the Association of British Clinical Diabetologist’s (ABCD) DIYAPS audit programme.
Authors:
TSJ Crabtree, S Hussain, B Mendis, T Gazis, R Herring, I Idris, REJ Ryder, EG Wilmot
The effect of semaglutide on alanine aminotransferase (ALT) levels: results from the Association of British Clinical Diabetologists (ABCD) nationwide audit.
Authors:
TSJ Crabtree, DK Sennik, A Bickerton, D Barnes, S Sivappriyan, K Adamson, SM Phillips, A Evans, N Larsen, A Panesar, ML Cull, IW Gallen, IR Idris, REJ Ryder on behalf of all ABCD Semaglutide audit contributors
HbA1c and weight changes with semaglutide at 6- and 12-months post commencement: Updated results from the ABCD Semaglutide audit.
Authors:
BCT Field, TSJ Crabtree, K Adamson, D Barnes, S Sivappriyan, A. Bickerton, A Gallagher, IW Gallen, I Idris, REJ Ryder; on behalf of ABCD Semaglutide audit contributors
Factors predicting achievement of recommend time-in-range at 6-months postcommencement amongst closed-loop users with elevated baseline HbA1c levels.
Authors:
TSJ Crabtree, TP Griffin, P Narendran, G Gallen, J Elliott, YW Yap, A Lumb, P Hammond, REJ Ryder, P Choudhary, EG Wilmot on behalf of all ABCD Closed-Loop Audit contributors.
Changes in HbA1c and sensor glucometrics 6-months following HCL commencement in individuals with HbA1c³86mmol/mol: Sub-analysis from the ABCD Closed-Loop audit of the NHS England Pilot.
Authors:
TSJ Crabtree TP Griffin, P Narendran, MA Karamat, G Gallen, J Elliott, Z Bawlchhim, A Chapman, A Lumb, P Hammond, REJ Ryder, P Choudhary, EG Wilmot on behalf of all ABCD Closed-Loop Audit contributors.
Who is using the OmniPod® DASH in the Association of British Clinical Diabetologists (ABCD) Audit: An interim report of baseline characteristics.
Authors:
TSJ Crabtree, M Haq, E Gatdula, N Hassan, J Varghese, K Bull, A Lumb, L Leelarathna, P Narendran, S Hussain, F Gibb, P Hammond, P Choudhary, EG Wilmot on behalf of all ABCD Worldwide Omnipod Audit contributors.
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
Authors:
